SYNOPSYS INC (SYP.DE) Fundamental Analysis & Valuation

FRA:SYP • US8716071076

379.9 EUR
+10.45 (+2.83%)
Last: Mar 5, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This SYP.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to SYP. SYP was compared to 116 industry peers in the Software industry. While SYP is still in line with the averages on profitability rating, there are concerns on its financial health. SYP is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. SYP.DE Profitability Analysis

1.1 Basic Checks

  • In the past year SYP was profitable.
  • SYP had a positive operating cash flow in the past year.
  • SYP had positive earnings in each of the past 5 years.
  • Each year in the past 5 years SYP had a positive operating cash flow.
SYP.DE Yearly Net Income VS EBIT VS OCF VS FCFSYP.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -5B -10B -15B

1.2 Ratios

  • SYP has a Return On Assets (2.76%) which is comparable to the rest of the industry.
  • SYP has a Return On Equity (4.70%) which is in line with its industry peers.
  • SYP has a Return On Invested Capital of 1.45%. This is comparable to the rest of the industry: SYP outperforms 50.86% of its industry peers.
  • SYP had an Average Return On Invested Capital over the past 3 years of 7.77%. This is below the industry average of 12.58%.
  • The 3 year average ROIC (7.77%) for SYP is well above the current ROIC(1.45%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 2.76%
ROE 4.7%
ROIC 1.45%
ROA(3y)10.66%
ROA(5y)10.22%
ROE(3y)16.63%
ROE(5y)16.41%
ROIC(3y)7.77%
ROIC(5y)8.83%
SYP.DE Yearly ROA, ROE, ROICSYP.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • SYP's Profit Margin of 18.89% is fine compared to the rest of the industry. SYP outperforms 75.86% of its industry peers.
  • In the last couple of years the Profit Margin of SYP has remained more or less at the same level.
  • SYP has a Operating Margin of 12.97%. This is in the better half of the industry: SYP outperforms 63.79% of its industry peers.
  • SYP's Operating Margin has declined in the last couple of years.
  • SYP's Gross Margin of 76.98% is in line compared to the rest of the industry. SYP outperforms 56.90% of its industry peers.
  • SYP's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 12.97%
PM (TTM) 18.89%
GM 76.98%
OM growth 3Y-19.79%
OM growth 5Y-5.43%
PM growth 3Y-3.98%
PM growth 5Y0.93%
GM growth 3Y-1.5%
GM growth 5Y-0.37%
SYP.DE Yearly Profit, Operating, Gross MarginsSYP.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. SYP.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SYP is destroying value.
  • SYP has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for SYP has been increased compared to 5 years ago.
  • Compared to 1 year ago, SYP has a worse debt to assets ratio.
SYP.DE Yearly Shares OutstandingSYP.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
SYP.DE Yearly Total Debt VS Total AssetsSYP.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.2 Solvency

  • An Altman-Z score of 3.05 indicates that SYP is not in any danger for bankruptcy at the moment.
  • SYP's Altman-Z score of 3.05 is in line compared to the rest of the industry. SYP outperforms 59.48% of its industry peers.
  • SYP has a Debt/Equity ratio of 0.48. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of SYP (0.48) is worse than 65.52% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Altman-Z 3.05
ROIC/WACC0.13
WACC10.79%
SYP.DE Yearly LT Debt VS Equity VS FCFSYP.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B -10B 20B

2.3 Liquidity

  • SYP has a Current Ratio of 1.62. This is a normal value and indicates that SYP is financially healthy and should not expect problems in meeting its short term obligations.
  • SYP's Current ratio of 1.62 is in line compared to the rest of the industry. SYP outperforms 56.03% of its industry peers.
  • SYP has a Quick Ratio of 1.52. This is a normal value and indicates that SYP is financially healthy and should not expect problems in meeting its short term obligations.
  • SYP's Quick ratio of 1.52 is in line compared to the rest of the industry. SYP outperforms 55.17% of its industry peers.
Industry RankSector Rank
Current Ratio 1.62
Quick Ratio 1.52
SYP.DE Yearly Current Assets VS Current LiabilitesSYP.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. SYP.DE Growth Analysis

3.1 Past

  • SYP shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.77%.
  • Measured over the past years, SYP shows a quite strong growth in Earnings Per Share. The EPS has been growing by 18.54% on average per year.
  • SYP shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.12%.
  • Measured over the past years, SYP shows a quite strong growth in Revenue. The Revenue has been growing by 13.87% on average per year.
EPS 1Y (TTM)6.77%
EPS 3Y13.39%
EPS 5Y18.54%
EPS Q2Q%24.42%
Revenue 1Y (TTM)15.12%
Revenue growth 3Y15.19%
Revenue growth 5Y13.87%
Sales Q2Q%65.52%

3.2 Future

  • SYP is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.48% yearly.
  • The Revenue is expected to grow by 14.92% on average over the next years. This is quite good.
EPS Next Y12.88%
EPS Next 2Y15.28%
EPS Next 3Y16.25%
EPS Next 5Y14.48%
Revenue Next Year36.66%
Revenue Next 2Y22.98%
Revenue Next 3Y18.94%
Revenue Next 5Y14.92%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SYP.DE Yearly Revenue VS EstimatesSYP.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B
SYP.DE Yearly EPS VS EstimatesSYP.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

1

4. SYP.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • SYP is valuated quite expensively with a Price/Earnings ratio of 32.22.
  • The rest of the industry has a similar Price/Earnings ratio as SYP.
  • SYP is valuated rather expensively when we compare the Price/Earnings ratio to 26.74, which is the current average of the S&P500 Index.
  • SYP is valuated quite expensively with a Price/Forward Earnings ratio of 25.64.
  • SYP's Price/Forward Earnings is on the same level as the industry average.
  • SYP's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 24.82.
Industry RankSector Rank
PE 32.22
Fwd PE 25.64
SYP.DE Price Earnings VS Forward Price EarningsSYP.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SYP indicates a slightly more expensive valuation: SYP is more expensive than 62.07% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 58.9
SYP.DE Per share dataSYP.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • SYP's earnings are expected to grow with 16.25% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.5
PEG (5Y)1.74
EPS Next 2Y15.28%
EPS Next 3Y16.25%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SYP.DE Dividend Analysis

5.1 Amount

  • SYP does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SYP.DE Fundamentals: All Metrics, Ratios and Statistics

SYNOPSYS INC

FRA:SYP (3/5/2026, 7:00:00 PM)

379.9

+10.45 (+2.83%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-25
Earnings (Next)05-26
Inst Owners93.54%
Inst Owner ChangeN/A
Ins Owners0.41%
Ins Owner ChangeN/A
Market Cap72.68B
Revenue(TTM)7.05B
Net Income(TTM)1.33B
Analysts80.65
Price Target480.24 (26.41%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.27%
Min EPS beat(2)-10.9%
Max EPS beat(2)2.36%
EPS beat(4)3
Avg EPS beat(4)0.56%
Min EPS beat(4)-10.9%
Max EPS beat(4)6.25%
EPS beat(8)5
Avg EPS beat(8)0.25%
EPS beat(12)9
Avg EPS beat(12)0.93%
EPS beat(16)12
Avg EPS beat(16)1.17%
Revenue beat(2)0
Avg Revenue beat(2)-2.56%
Min Revenue beat(2)-3.51%
Max Revenue beat(2)-1.62%
Revenue beat(4)0
Avg Revenue beat(4)-2.36%
Min Revenue beat(4)-3.51%
Max Revenue beat(4)-1.62%
Revenue beat(8)0
Avg Revenue beat(8)-2.26%
Revenue beat(12)0
Avg Revenue beat(12)-2.75%
Revenue beat(16)0
Avg Revenue beat(16)-4.52%
PT rev (1m)-0.84%
PT rev (3m)-3.04%
EPS NQ rev (1m)-0.16%
EPS NQ rev (3m)8.9%
EPS NY rev (1m)0.13%
EPS NY rev (3m)2.04%
Revenue NQ rev (1m)-0.12%
Revenue NQ rev (3m)0.62%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.53%
Valuation
Industry RankSector Rank
PE 32.22
Fwd PE 25.64
P/S 12
P/FCF N/A
P/OCF 55.75
P/B 2.99
P/tB N/A
EV/EBITDA 58.9
EPS(TTM)11.79
EY3.1%
EPS(NY)14.82
Fwd EY3.9%
FCF(TTM)-68.79
FCFYN/A
OCF(TTM)6.81
OCFY1.79%
SpS31.65
BVpS127.1
TBVpS-50.48
PEG (NY)2.5
PEG (5Y)1.74
Graham Number183.62
Profitability
Industry RankSector Rank
ROA 2.76%
ROE 4.7%
ROCE 2.06%
ROIC 1.45%
ROICexc 1.55%
ROICexgc 32.83%
OM 12.97%
PM (TTM) 18.89%
GM 76.98%
FCFM N/A
ROA(3y)10.66%
ROA(5y)10.22%
ROE(3y)16.63%
ROE(5y)16.41%
ROIC(3y)7.77%
ROIC(5y)8.83%
ROICexc(3y)10.92%
ROICexc(5y)12.04%
ROICexgc(3y)46.31%
ROICexgc(5y)58.99%
ROCE(3y)11.04%
ROCE(5y)12.54%
ROICexgc growth 3Y-30.11%
ROICexgc growth 5Y-5.25%
ROICexc growth 3Y-54.14%
ROICexc growth 5Y-30.5%
OM growth 3Y-19.79%
OM growth 5Y-5.43%
PM growth 3Y-3.98%
PM growth 5Y0.93%
GM growth 3Y-1.5%
GM growth 5Y-0.37%
F-Score3
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Debt/EBITDA 8.55
Cap/Depr 2551.48%
Cap/Sales 238.88%
Interest Coverage 2.59
Cash Conversion 96.4%
Profit Quality N/A
Current Ratio 1.62
Quick Ratio 1.52
Altman-Z 3.05
F-Score3
WACC10.79%
ROIC/WACC0.13
Cap/Depr(3y)948.17%
Cap/Depr(5y)656.53%
Cap/Sales(3y)84.22%
Cap/Sales(5y)54.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.77%
EPS 3Y13.39%
EPS 5Y18.54%
EPS Q2Q%24.42%
EPS Next Y12.88%
EPS Next 2Y15.28%
EPS Next 3Y16.25%
EPS Next 5Y14.48%
Revenue 1Y (TTM)15.12%
Revenue growth 3Y15.19%
Revenue growth 5Y13.87%
Sales Q2Q%65.52%
Revenue Next Year36.66%
Revenue Next 2Y22.98%
Revenue Next 3Y18.94%
Revenue Next 5Y14.92%
EBIT growth 1Y-32.51%
EBIT growth 3Y-7.6%
EBIT growth 5Y7.68%
EBIT Next Year82.5%
EBIT Next 3Y37.9%
EBIT Next 5Y15.28%
FCF growth 1Y-1460.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y7.93%
OCF growth 3Y-4.41%
OCF growth 5Y8.9%

SYNOPSYS INC / SYP.DE FAQ

What is the ChartMill fundamental rating of SYNOPSYS INC (SYP.DE) stock?

ChartMill assigns a fundamental rating of 4 / 10 to SYP.DE.


What is the valuation status for SYP stock?

ChartMill assigns a valuation rating of 1 / 10 to SYNOPSYS INC (SYP.DE). This can be considered as Overvalued.


How profitable is SYNOPSYS INC (SYP.DE) stock?

SYNOPSYS INC (SYP.DE) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for SYP stock?

The Price/Earnings (PE) ratio for SYNOPSYS INC (SYP.DE) is 32.22 and the Price/Book (PB) ratio is 2.99.


How financially healthy is SYNOPSYS INC?

The financial health rating of SYNOPSYS INC (SYP.DE) is 3 / 10.